Avanos Medical, Inc. (NYSE:AVNS) Shares Acquired by William Blair Investment Management LLC

William Blair Investment Management LLC boosted its stake in Avanos Medical, Inc. (NYSE:AVNS) by 2.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,406,210 shares of the company’s stock after purchasing an additional 28,608 shares during the period. William Blair Investment Management LLC’s holdings in Avanos Medical were worth $22,387,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in AVNS. Quarry LP acquired a new stake in Avanos Medical in the 3rd quarter valued at approximately $42,000. KBC Group NV increased its holdings in Avanos Medical by 63.0% in the 3rd quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after purchasing an additional 1,095 shares during the last quarter. Intech Investment Management LLC acquired a new stake in Avanos Medical in the 3rd quarter valued at approximately $207,000. Atom Investors LP acquired a new stake in Avanos Medical in the 3rd quarter valued at approximately $210,000. Finally, EP Wealth Advisors LLC acquired a new stake in Avanos Medical in the 3rd quarter valued at approximately $212,000. Institutional investors and hedge funds own 95.17% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com upgraded shares of Avanos Medical from a “hold” rating to a “buy” rating in a report on Wednesday.

Insiders Place Their Bets

In other news, SVP Kerr Holbrook sold 7,000 shares of Avanos Medical stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $15.25, for a total transaction of $106,750.00. Following the completion of the sale, the senior vice president now directly owns 82,047 shares of the company’s stock, valued at approximately $1,251,216.75. The trade was a 7.86 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.90% of the company’s stock.

Avanos Medical Stock Performance

NYSE:AVNS opened at $14.66 on Wednesday. The company has a fifty day simple moving average of $15.87 and a two-hundred day simple moving average of $18.84. The company has a market cap of $674.59 million, a price-to-earnings ratio of 43.13 and a beta of 1.17. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. Avanos Medical, Inc. has a 52 week low of $14.25 and a 52 week high of $25.36.

Avanos Medical (NYSE:AVNS) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.40 by $0.03. The business had revenue of $179.60 million during the quarter, compared to the consensus estimate of $177.23 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. As a group, equities analysts anticipate that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.